Related Experiment Video
Updated: Sep 23, 2025
10:21
Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
551
Identifying key genes and functionally enriched pathways in Th2-high asthma by weighted gene co-expression network
Yao Cao1,2,3, Yi Wu1,2,3, Li Lin1,2,3
1Division of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan, People's Republic of China.
BMC Medical Genomics
|May 13, 2022
Summary
This study identifies key genes and pathways in Th2-high asthma using weighted gene coexpression network analysis (WGCNA). These findings offer new insights for diagnosing and managing asthma.
Area of Science:
- Genomics
- Immunology
- Bioinformatics
Background:
- Asthma is a chronic airway inflammatory disease.
- Th1/Th2 cell imbalance is crucial in asthma pathogenesis.
- Identifying specific gene markers in Th2-high asthma is important for targeted therapies.
Purpose of the Study:
- To identify key asthma-related genes in Th2-high asthma.
- To explore functionally enriched pathways in Th2-high asthma.
- To utilize weighted gene coexpression network analysis (WGCNA) for novel insights.
Main Methods:
- Gene expression data from asthma patients and controls (GSE4302) were analyzed.
- Weighted gene coexpression network analysis (WGCNA) was employed to construct gene networks.
- Gene Ontology (GO) and Receiver Operating Characteristic (ROC) curve analyses were performed for functional enrichment and diagnostic capacity assessment.
Main Results:
- A weighted gene coexpression network identified a 'red' module strongly associated with Th2-high asthma.
- Eight hub genes (TPSB2, CPA3, ITLN1, CST1, SERPINB10, CEACAM5, CHD26, P2RY14) were identified within this module.
- These hub genes demonstrated excellent diagnostic efficiency for distinguishing Th2-high and Th2-low asthma phenotypes.
Conclusions:
- WGCNA provides a novel approach to understanding Th2-high asthma.
- The identified hub genes and pathways may aid in the diagnosis and management of Th2-high asthma.
- Further research into these genetic markers could lead to improved therapeutic strategies.
More Related Videos
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
01:20Asthma: Pathogenesis and Management
676
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
676
01:30Asthma-IV: Diagnostic and Management
2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
01:29Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
01:24Asthma-III: Symptoms and Complications
2.7K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
559
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
559